Machine learning modeling of patient health signals informs long-term survival on immune checkpoint inhibitor therapy
Gerald J. Sun(AstraZeneca (United States)), Etai Jacob(AstraZeneca (United States)), Gary J. Doherty(Cambridge University Hospitals NHS Foundation Trust), Allen C. Chen(AstraZeneca (United Kingdom)), Damián E. Bikiel(AstraZeneca (United States)), Dejan Pavlović(AstraZeneca (United States)), Ross Stewart(AstraZeneca (United Kingdom)), Gustavo Arango-Argoty(AstraZeneca (South Korea)), Zhongwu Lai(AstraZeneca (United States))
Cited by 2